Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes
Clinical trial NCT00799448 · TERMINATED
Trial details
- NCT number
- NCT00799448
- Sponsor
- Novo Nordisk A/S
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-16
- Primary completion
- 2004-09-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.